1 - 25 of 28 results for author:"Boussiotis V.A." in Literature citations
Results Customize
› Repeat search in UniProtKB (10)
| Rap1-interacting adapter molecule (RIAM) associates with the plasma membrane via a proximity detector. Wynne J.P., Wu J., Su W., Mor A., Patsoukis N., Boussiotis V.A., Hubbard S.R., Philips M.R. J. Cell Biol. 199:317-330(2012) · Mapped (5) |
| Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Patsoukis N., Brown J., Petkova V., Liu F., Li L., Boussiotis V.A. Sci Signal 5:ra46-ra46(2012) · Mapped (9) |
| Rap1-GTP-interacting adaptor molecule (RIAM) protein controls invasion and growth of melanoma cells. Hernandez-Varas P., Colo G.P., Bartolome R.A., Paterson A., Medrano-Fernandez I., Arellano-Sanchez N., Cabanas C., Sanchez-Mateos P., Lafuente E.M., Boussiotis V.A. et al. J. Biol. Chem. 286:18492-18504(2011) · Mapped (4) |
| Rap1A regulates generation of T regulatory cells via LFA-1-dependent and LFA-1-independent mechanisms. Li L., Kim J., Boussiotis V.A. Cell. Immunol. 266:7-13(2010) · Mapped (17) |
| IL-1beta-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells. Li L., Kim J., Boussiotis V.A. J. Immunol. 185:4148-4153(2010) · Mapped (7) |
| RIAM regulates the cytoskeletal distribution and activation of PLC-gamma1 in T cells. Patsoukis N., Lafuente E.M., Meraner P., Kim J., Dombkowski D., Li L., Boussiotis V.A. Sci Signal 2:ra79-ra79(2009) · Mapped (10) |
| The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naive T cells. Zhou D., Medoff B.D., Chen L., Li L., Zhang X.F., Praskova M., Liu M., Landry A., Blumberg R.S., Boussiotis V.A. et al. Proc. Natl. Acad. Sci. U.S.A. 105:20321-20326(2008) · Mapped (11) |
| Control and regulation of peripheral tolerance in allergic inflammatory disease: therapeutic consequences. Li L., Boussiotis V.A. Chem Immunol Allergy 94:178-188(2008) · Mapped (9) |
| Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling. Cardoso B.A., Martins L.R., Santos C.I., Nadler L.M., Boussiotis V.A., Cardoso A.A., Barata J.T. Leukemia 23:206-208(2009) · Mapped (13) |
| Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin alphaIIbbeta3. Watanabe N., Bodin L., Pandey M., Krause M., Coughlin S., Boussiotis V.A., Ginsberg M.H., Shattil S.J. J. Cell Biol. 181:1211-1222(2008) · Mapped (17) |
| Active Rap1, a small GTPase that induces malignant transformation of hematopoietic progenitors, localizes in the nucleus and regulates protein expression. Lafuente E.M., Iwamoto Y., Carman C.V., van Puijenbroek A.A., Constantine E., Li L., Boussiotis V.A. Leuk. Lymphoma 48:987-1002(2007) · Mapped (3) |
| Twisted gastrulation (Tsg) is regulated by Tob and enhances TGF-beta signaling in activated T lymphocytes. Tzachanis D., Li L., Lafuente E.M., Berezovskaya A., Freeman G.J., Boussiotis V.A. Blood 109:2944-2952(2007) · Mapped (12) |
| A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Li L., Iwamoto Y., Berezovskaya A., Boussiotis V.A. Nat. Immunol. 7:1157-1165(2006) · Mapped (15) |
| CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation. Appleman L.J., Chernova I., Li L., Boussiotis V.A. Cell Cycle 5:2123-2129(2006) · Mapped (3) |
| Rap1 regulation of RIAM and cell adhesion. Lafuente E., Boussiotis V.A. Meth. Enzymol. 407:345-358(2006) · Mapped (6) |
| RIAM, an Ena/VASP and profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Lafuente E.M., van Puijenbroek A.A., Krause M., Carman C.V., Freeman G.J., Berezovskaya A., Constantine E., Springer T.A., Gertler F.B., Boussiotis V.A. |
| Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics. Krause M., Leslie J.D., Stewart M., Lafuente E.M., Valderrama F., Jagannathan R., Strasser G.A., Rubinson D.A., Liu H., Way M. et al. Dev. Cell 7:571-583(2004) · UniProtKB (4) |
| Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. Barata J.T., Silva A., Brandao J.G., Nadler L.M., Cardoso A.A., Boussiotis V.A. J. Exp. Med. 200:659-669(2004) · Mapped (8) |
| Differential localization and function of ADP-ribosylation factor-6 in anergic human T cells: a potential marker for their identification. Tzachanis D., Appleman L.J., Van Puijenbroek A.A., Berezovskaya A., Nadler L.M., Boussiotis V.A. J. Immunol. 171:1691-1696(2003) · Mapped (3) |
| cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression. Grader-Beck T., van Puijenbroek A.A., Nadler L.M., Boussiotis V.A. Blood 101:998-1006(2003) · Mapped (3) |
| CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. Appleman L.J., van Puijenbroek A.A., Shu K.M., Nadler L.M., Boussiotis V.A. J. Immunol. 168:2729-2736(2002) · Mapped (11) |
| Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses. Tzachanis D., Berezovskaya A., Nadler L.M., Boussiotis V.A. Blood 99:1465-1473(2002) · Mapped (8) |
| CTLA-4 regulates cell cycle progression during a primary immune response. Greenwald R.J., Oosterwegel M.A., van der Woude D., Kubal A., Mandelbrot D.A., Boussiotis V.A., Sharpe A.H. Eur. J. Immunol. 32:366-373(2002) · Mapped (16) |
| CTLA-4 regulates induction of anergy in vivo. Greenwald R.J., Boussiotis V.A., Lorsbach R.B., Abbas A.K., Sharpe A.H. Immunity 14:145-155(2001) · Mapped (10) |
| PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R. et al. |